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ABSTRACT 
 
 
Polyesters are extensively used in drug delivery because of their controllable 
biodegradation properties and perceived favourable cytocompatibility. However, new 
ester-based materials are continually being sought which can be produced from readily 
accessible monomers, which can be tuned for drug encapsulation and which retain good 
cellular compatibilities. In this study, 5 polyesters of similar molar mass were 
synthesized by reacting 1,10-decanediol with different ratios of succinic 
acid/phenylsuccinic acid and the effect of the phenyl side-chain group addition on 
polymer properties relevant to drug delivery was investigated. A polymer with a 70/30 
ratio of succinic acid and phenylsuccinic acid was selected based on its ability to 
encapsulate a model dye in nanoparticle (NP) formulations, and was found to be slowly 
degradable in phosphate buffered saline (PBS) but more rapidly degraded in the 
presence of a lipase. The compatibility of NP formulations of this polymer either with 
or without a Pluronic F68 stabilizing coating was assessed in vitro using the C3A 
hepatocyte cell line. Cell viability was assessed, at NP concentrations ranging from 4.68 
- 300 μg/mL 24 h post exposure, using the Alamar Blue, CDFA and Neutral Red assays. 
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C3A cells internalised both coated and uncoated polyester NPs to a similar extent, with 
uptake observed to increase over time (10 - 1440 min). Although cell viability was 
greater than 80% at the concentrations tested, in all assays, it was found that a Pluronic 
F68 coated poly (decanediol-phenylsuccinate-co-succinate) stimulated significant DNA 
damage driven by an oxidant mechanism, whereas the non-coated polyester analogue 
and the Pluronic F68 alone had no effect. The results obtained suggest that new 
polyesters can be synthesised with desirable properties from the materials perspective 
but formulation with additional excipients requires careful evaluation for drug delivery 
applications. 
Keywords: Polyester; polycondensation; nanoparticles; polymer; cytotoxicity; 
hepatocyte; in vitro; uptake  
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1. Introduction 
In recent years, there has been a renewed interest in polyesters as drug delivery devices 
due to their favorable biocompatibility and controllable biodegradation profiles [1-4]. 
Accordingly, polyester materials are regarded as a material of choice for biomedical applications 
including drug delivery [5-9], as diagnostic agents [10, 11] and for tissue engineering [12-16]. For 
these applications, polyesters with a range of physicochemical, biomechanical and biological 
properties are needed, along with appropriate biocompatibility, biodegradability and storage 
stability [17]. A balance of these properties can be obtained through incorporation of suitable 
constituent monomers into the polyester backbone. 
For use as therapeutic agents, polyesters need to have strong associative interactions with 
active ingredients. An ability to release the drug at a suitable rate for therapy is important to reduce 
frequency of treatment [18]. Accordingly, there have been many variations made on the 
compositions and co-monomers used for polyesters, with a view to obtaining the most favorable 
controlled drug incorporation and release properties. More recently, there has been a strong 
economic and ecological drive for polymer precursors to be derived from sustainable building 
blocks, and for polymers to be produced with minimal use of solvents [19]. The synthesis of 
polyesters for drug delivery has been very thoroughly explored, with many variations around the 
use of poly(lactides), poly(caprolactone) and poly(carbonates) [3, 20, 21]. However, these 
polyesters by themselves are not easy to formulate into nanoparticles that are stable for storage in 
solution or for intravenous injection. Accordingly, methods are needed to enhance the colloidal 
properties of polyester nanoparticles, and the most simple of these, and thus the most appealing 
from an industrial perspective, is the surface adsorption to the nanoparticles of stabilising layers. 
The concept of sterically shielding hydrophobic polyester surfaces by attaching hydrophilic 
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polymers is well-established, with an extensive literature on adsorbed amphiphilic block co-
polymers [22-27]. These types of stabilized nanoparticles have long been known to evade uptake 
by the mononuclear phagocyte system (MPS),[28] and so for practical drug delivery purposes there 
is a strong rationale to develop polyesters which are easy to synthesise from renewable resources, 
and which can be easily formulated into drug-loaded nanoparticles.  
Here we report the synthesis of linear polyesters from the readily available monomers 
succinic acid, phenyl succinic acid and 1, 10-decanediol, with progressive variation with respect 
to the phenyl side chain content from the polyester backbone. The polymers were made using 
scandium (III) triflate as a catalyst under solvent-free conditions [29-33] and evaluated for drug-
loading via nanoprecipitation in the presence of coumarin-6 dye. The polymer exhibiting the 
highest dye loading was tested for colloidal and hydrolytic stability when formulated into 
nanoparticles (NPs). In addition, the toxicity of polyester nanoparticles, with and without a 
sterically-stabilizing adsorbed Pluronic F68 block co-polymer layer. The toxicity of these NPs 
was assessed in vitro, using the human C3A hepatocyte cell line. Hepatocytes were selected as the 
liver is the primary site of nanoparticle accumulation following exposure via different routes (e.g. 
intratracheal instillation, ingestion, intravenous injection), and existing evidence suggests that 
C3A cells respond similarly to primary human hepatocytes [34-37]. The internalization of coated 
and uncoated polymer nanoparticles by hepatocytes was assessed over time, and their effects on 
cell viability evaluated using three assays; Alamar Blue, Neutral Red, and 5-CFDA-AM [5-
carboxyfluorescein diacetate, acetoxymethyl ester] CFDA-AM. The ability of nanoparticles to 
stimulate cytokine production (IL-8) and cause genotoxicity (DNA damage) was assessed in order 
to evaluate sub-lethal impacts on cell function. These data showed that while the new selected 
polyesters were rapidly internalized with or without the Pluronic F68 coating, there were 
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differences in DNA damage induced by the NP formulations which were a consequence of the 
combination of the coating and ‘core’ NP, and not a function of the individual components alone. 
2. Experimental Section 
2.1. Materials 
Succinic acid (ACS reagent, ≥99.0%), Phenylsuccinic acid (98%), 1,10-Decanediol (98%), 
Scandium(III) triflate (99%), Coumarin-6 (98%),  Pluronic F-68, deuterated chloroform (CDCl3), 
1 mM sodium pyruvate, 1% non- essential amino acids, phosphate buffer saline solution, CFDA-
AM,  Neutral Red, acetic acid, 95% ethanol, ammonium chloride, Triton-X100, DAPI, H2O2, 
HBSS, low melting point agarose, agarose , lysis buffer base, dimethyl sulfoxide, HEPES, 
potassium chloride, Ethylenediaminetetraacetic acid [EDTA], Bovine Serum Albumin, sodium 
hydroxide, Tris base and GelRed were purchased from Sigma-Aldrich. All solvents were 
purchased from Fischer Scientific UK.  
Cell culture reagents including MEM medium, foetal calf serum (FCS), 2 mM L-glutamine, 
100 U/ml penicillin/streptomycin, phenol red free MEM medium, 10 x trypsin (2.5%) and 0.4% 
v/v Trypan Blue were purchased from Gibco, Invitrogen. The human hepatocyte cell line C3A was 
purchased from ATCC, Manassas, VA, USA. 
2.2. Measurements 
Nuclear magnetic resonance (NMR) spectra of 1H NMR and 13C NMR were recorded at 
400 MHz (1H) and 101 MHz (13C) using a Bruker DPX400 Ultrashield spectrometer and 
deuterated chloroform (CDCl3) as the solvent. Spectral analysis was performed using 
MestRENova 6.0.2 software copyright© 2009 Mestrelab Research S.L. All chemical shifts are 
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reported in ppm (δ) relative to tetramethylsilane, referenced to the chemical shifts of residual 
solvent resonances (CDCl3: δH 7.26, δC 77.16). 
Fourier transform infrared (FTIR) spectroscopy was performed on solid or liquid samples 
using a Cary 630 FTIR spectrophotometer equipped with a single bounce diamond ATR. 
MicroLab software was used for data analysis. 
A Polymer Laboratories GPC 50 instrument was used to determine Mn (number-average 
molecular weight), Mw (weight average molecular weight) and Ð (polydispersity index, Mw / Mn). 
The instrument was fitted with a Polymer Laboratories PLgel guard column (50 × 7.5 mm, 8 µm) 
followed by a pair of PLgel Mixed-D columns (300 × 7.5 mm, 8 µm) and a refractive index 
detector. The flow rate of HPLC grade CHCl3 at 30 °C was 1 mL min
-1. The column calibration 
was achieved using narrow molar mass distribution polystyrene standards. Polymer Laboratories 
Cirrus 3.0 software was used for data analysis. 
The thermal properties of the polymers i.e. Tm (melting temperature) and Tg (glass 
transition temperature) were probed using a TA-Q2000 DSC (TA Instruments) under a nitrogen 
atmosphere. Typically, the samples (5–10 mg) were exposed to two cooling-heating cycles from 
–90 to 150 °C at a rate of 10 °C min-1.  
The particle sizes (z-average diameter) of nanoparticles were measured in HPLC water 
determined by dynamic light scattering (DLS) using a NanoZS instrument (Malvern, UK) at 25 
°C using 633 nm (4 mW) wavelength laser. The scattered light was detected at an angle of 173˚ 
and analysis was performed using zetasizer software version 7.03. The zeta potentials of the NPs 
were determined in HEPES 10 mM buffer (pH 7.4).  The size and surface zeta potentials of NPs 
were also measured in complete MEM cell culture medium (MEM medium supplemented with 
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10% heat-inactivated foetal calf serum (FCS), 2 mM L-glutamine, 100 U/mL 
penicillin/streptomycin, 1 mM sodium pyruvate  and 1% non-essential amino acids) containing 
125 µg/mL of NPs. 
A Tecnai G2 (FEI, Oregon, USA) microscope was utilized for transmission electron 
microscopy (TEM). One drop of polymer suspension in HPLC grade water (typically 25–50 μg 
mL−1) was dropped onto a copper grid and allowed to dry in air. The sample was put on a copper 
grid and allowed to air dry. The imaging was performed without staining. 
A Zeiss LSM880 confocal microscope was used for imaging uptake of labelled polymers 
and nanoparticles, and the Zeiss Zen program was used for data analysis. 
2.3. Methods 
2.3.1. Synthesis of Polyesters 
Poly(decamethylene succinate) [PDeMS], poly(decamethylene phenylsuccinate) [PDsMPS] and 
their copolymers poly(decamethylene succinate-co-phenylsuccinate) [PDeMS-co-PS] were 
synthesized by a solvent-free melt polycondensation method (Scheme 1). The diacid and diol ratio 
was maintained at 1:1 in all polycondensation reactions. A scandium (III) triflate: diol ratio of 
5.10-4 (0.05 mol%) was used in all the reactions. Polymer names, abbreviations and codes along 
with feed compositions are given in Table 1. 
Table 1. Synthesis of polyesters with different feed ratio (mol%) of succinic acid, phenylsuccinic 
acid and 1,10- decanediol using scandium (III) triflate as catalyst. 
Polymer$ Code 
Feed ratio (mol%) Scandium (III) 
triflate 
(mol% of diol) Succinic acid 
Phenylsuccinic 
acid 
1, 10-  
Decanediol 
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Poly(decamethylene
succinate) 
(PDeMS) 
P01 
100  
(0.61 g, 5.15 
mmol) 
0 
100 # 
 
0.05* 
 
Poly(decamethylene 
succinate-co-
phenylsuccinate) 
(PDeMS-co-PS) 
P02 
70 
(0.42 g, 3.60  
mmol) 
30  
(0.30 g, 1.54 
mmol) 
100 # 
 
0.05* 
 
P03 
50 
(0.30 g, 2.57 
mmol) 
50 
(0.50 g, 2.57 
mmol) 
100 # 
 
0.05* 
 
P04 
30 
(0.18 g, 1.54 
mmol) 
70 
(0.70 g, 3.60 
mmol) 
100 # 
 
0.05* 
 
Poly(decamethylene
- phenylsuccinate) 
(PDeMPS) 
P05 
0 100  
(1 g, 5.15 
mmol) 
100 # 
 
0.05* 
 
$Reaction was conducted for 21 h in bulk at 125 °C under reduced pressure. #  For 1, 10- 
Decanediol 0.90 g, 5.15 mmol.* For Scandium (III) triflate1.27 mg, 2.58 μmol 
 
2.3.1.1. Poly(decamethylenesuccinate) [PDeMS] polymer (P01) 
The polymer was synthesized by mixing succinic acid (0.61 g, 5.2 mmol, 1 eq) and 1, 10- 
decanediol (0.90 g, 5.2 mmol, 1 eq) in a reaction vessel at 80 °C for 30 min under stirring for 
melting and mixing of the monomers. Scandium (III) triflate (1.27 mg, 2.58 μmol, 5.10-4 eq) was 
added followed by purging of the reaction mixture with nitrogen. The reaction was continued for 
3 h after increasing the temperature to 125 °C. The pressure was then reduced to 10-2 mbar and the 
reaction was further continued for 18 h after which the reaction was stopped, and the mixture was 
allowed to cool. The resultant polymer was purified by dissolving it in a small volume of acetone 
and precipitated in stirred cold methanol for three times. The precipitate was filtered and dried 
under vacuum to obtain a solid white powder in 94% yield. 
Mn: 11500 g mol
-1; Ð = 3.7 
1H NMR (400 MHz, CDCl3) δ (ppm) 4.07 (CO-O-CH2(C8H18)CH2, bt, 4H), 2.62 (CO-CH2-CH2-
CO, s, 4H), 1.61 (CH2-CH2(C6H12)CH2-CH2, m, 4H), 1.28 (C2H4(C6H12)C2H4, m, 12H). 
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13C NMR (101 MHz, CDCl3) δ (ppm)  172.5 (CO-CH2-CH2-CO), 65.0 (CO-O-CH2), 29.6 (CO-O-
CH2-CH2), 29.4 (CO-CH2-CH2-CO), 29.3 (CO-O-CH2CH2-CH2), 28.7 (CO-O-CH2CH2CH2-CH2),  
26.0 (CO-O-CH2CH2CH2CH2-CH2). 
FTIR wavenumber (cm-1): 3446 (O-H, stretching), 2920 (C-H, asymmetric stretching), 2852 (C-
H, symmetric stretching), 1722 (C=O, stretching), 1421 (C-H, bending), 1153 (C-O, stretching). 
2.3.1.2. Poly(decamethylene phenylsuccinate) [PDsMPS] polymer (P05) 
The polymer was synthesized by the same procedure as described above except instead of succinic 
acid, phenyl succinic acid (1.0 g, 5.2 mmol, 1eq) was incorporated as the diacid component 
reacting with 1, 10- decanediol (0.90 g, 5.2 mmol, 1 eq) using scandium (III) triflate (1.3 mg, 2.6 
μmol, 5.10-4 eq) as a catalyst. The resultant polymer was dissolved in a small volume of acetone 
and purified by precipitation in cold methanol three times followed by drying under vacuum to 
obtain a light brown viscous liquid material in 90% yield. 
Mn: 11600 g mol
-1; Ð = 3.2 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.28 (C6H5, ring protons, m, 5H), 4.06 (CO-O-
CH2(C8H18)CH2 and CO-CH(C6H5), m, 5H), 3.17 (CH(C6H5)-CH2-CO, m, 1H), 2.68 (CH(C6H5)-
CH2-CO, m, 1H), 1.55 (CH2- CH2(C6H12)CH2-CH2, m, 4H), 1.26-1.19 (C2H4(C6H12)C2H4, m, 
12H). 
13C NMR (101 MHz, CDCl3) δ (ppm)  173.1 (CO-CH(C6H5)-CH2-CO), 171.7 (CO-CH(C6H5)-
CH2-CO), 138.0, 128.9, 127.9, 127.6 (Ring carbon peaks), 65.0 (CH2-CO-O-CH2), 47.4 (O-CO-
CH(C6H5)-CH2-CO-O) , 37.8 (O-CO-CH(C6H5)-CH2-CO-O), 29.5 (CO-O-CH2-CH2), 29.2 (CO-
O-CH2CH2-CH2), 28.6 (CO-O-CH2CH2CH2-CH2), 25.8 (CO-O-CH2CH2CH2CH2-CH2). 
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FTIR wavenumber (cm-1): 3452 (O-H, stretching), 2925 (C-H, asymmetric stretching), 2854 (C-
H, symmetric stretching), 1729 (C=O, stretching), 1612 (aromatic C=C stretching), 1455 (C-H, 
bending), 1159 (C-O, stretching). 
2.3.1.3. Poly(decamethylene succinate-co-phenylsuccinate)  [PDeMS-co-PS] (P02, P03 and  
P04) 
The copolymers were synthesized by reacting succinic acid, phenylsuccinic acid and 1, 10-
decandiol. The feed ratio of succinic acid and phenylsuccinic acid has been given in table 3-1. The 
diacids : diol molar ratio was maintained at 1:1 in all polycondensation reactions.  
As an example, the synthesis of polymer (P02 polymer) with 70 mol% of succinic acid and 30 
mol% of phenylsuccinic acid is described here. Succinic acid (0.42 g, 3.6 mmol), phenylsuccinic 
acid (0.30 g, 1.5 mmol) and 1,10-decanediol (0.90 g, 5.2 mmol) were charged in a reaction vessel 
and heated to 80 °C for 30 min under stirring for melting and mixing of the  monomers. Scandium 
(III) triflate (1.3 mg, 2.6 μmol) was then added and the reaction was purged with nitrogen followed 
by increasing the reaction temperature to 125 °C. After 3 h of reaction, the pressure was reduced 
to 10-2 mbar and the reaction was continued for 18 h after which the reaction was stopped and the 
mixture was allowed to cool. The resultant polymer was dissolved in a small volume of acetone 
and precipitated in stirred cold methanol for three times. The precipitate was filtered, washed with 
methanol and dried under vacuum. 
The different feed ratios generated polymers with different physical properties ranging from off-
white solid powders to light brown viscous liquids, with yields from 90-95%.  
PDeMS-co-PS (P02) 
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Mn: 11500 g mol
-1; Ð = 2.9 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.28 (C6H5, ring protons, m, 2.22H), 4.07 (CO-O-
CH2(C8H18)CH2 and CO-CH(C6H5), m, 4.23H), 3.19 (CH(C6H5)-CH2-CO, m, 0.30H and 2.68 
(CH(C6H5)-CH2-CO), m, 0.30H), 2.62 (CO-CH2-CH2-CO), s, 2.80H), 1.61 (CH2-CH2(C6H12)CH2-
CH2, m, 4.00H), 1.28 (C2H4(C6H12)C2H4, m, 12.00H). 
13C NMR (101 MHz, CDCl3) δ (ppm)  172.9 (CO-CH(C6H5)-CH2-CO),  172.4 (CO-CH2-CH2-
CO), 171.6 (CO-CH(C6H5)-CH2-CO), 137.9, 128.7, 127.7, 127.5 (aromatic), 64.9 (CH2-CO-O-
CH2),  47.3 (O-CO-CH(C6H5)-CH2-CO-O), 37.7 (O-CO-CH(C6H5)-CH2-CO-O), 29.4 (CO-O-
CH2-CH2), 29.2 (CO-CH2-CH2-CO), 29.2 (CO-O-CH2CH2-CH2), 28.6 (CO-O-CH2CH2CH2-CH2), 
25.9 (CO-O-CH2CH2CH2CH2-CH2). 
FTIR wavenumber (cm-1): 3450 (O-H, stretching), 2920 (C-H, asymmetric stretching), 2852 (C-
H, symmetric stretching), 1723 (C=O, stretching), 1609 (aromatic C=C stretching), 1420 (C-H, 
bending), 1154 (C-O, stretching). 
PDeMS-co-PS (P03) 
Mn: 10100 g mol
-1; Ð = 3.4 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.28 (C6H5, ring protons, m, 2.92H), 4.07 (CO-O-
CH2(C8H18)CH2 and CO-CH(C6H5), m, 4.45H), 3.19 (CH(C6H5)-CH2-CO, m, 0.50H and 2.68 
(CH(C6H5)-CH2-CO), m,0.50H), 2.62 (CO-CH2-CH2-CO), s, 2.00H), 1.61 (CH2-CH2(C6H12)CH2-
CH2, m, 4.00H), 1.27 (C2H4(C6H12)C2H4, m, 12.05H). 
13C NMR (101 MHz, CDCl3) δ (ppm)  172.9 (CO-CH(C6H5)-CH2-CO),  172.4 (CO-CH2-CH2-
CO), 171.6 (CO-CH(C6H5)-CH2-CO), 137.9, 128.7, 127.7, 127.5 (aromatic), 64.9 (CH2-CO-O-
CH2),  47.3 (O-CO-CH(C6H5)-CH2-CO-O), 37.7 (O-CO-CH(C6H5)-CH2-CO-O), 29.4 (CO-O-
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CH2-CH2), 29.2 (CO-CH2-CH2-CO), 29.2 (CO-O-CH2CH2-CH2), 28.6 (CO-O-CH2CH2CH2-CH2), 
25.9 (CO-O-CH2CH2CH2CH2-CH2). 
FTIR wavenumber (cm-1): 3453 (O-H, stretching), 2925 (C-H, asymmetric stretching), 2854 (C-
H, symmetric stretching), 1731 (C=O, stretching), 1605 (aromatic C=C stretching), 1423 (C-H, 
bending), 1159 (C-O, stretching). 
PDeMS-co-PS (P04) 
Mn: 11000 g mol
-1; Ð = 3.1 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.28 (C6H5, ring protons, m, 4.15H), 4.06 (CO-O-
CH2(C8H18)CH2 and CO-CH(C6H5), m, 4.29H), 3.19 (CH(C6H5)-CH2-CO, m, 0.70H and 2.68 
(CH(C6H5)-CH2-CO), m, 0.70H), 2.61 (CO-CH2-CH2-CO), s, 1.30H), 1.55 (CH2-CH2(C6H12)CH2-
CH2, m, 4.00H), 1.26-1.20 (C2H4(C6H12)C2H4, m, 12.00H). 
13C NMR (101 MHz, CDCl3) δ (ppm)  172.9 (CO-CH(C6H5)-CH2-CO),  172.4 (CO-CH2-CH2-
CO), 171.6 (CO-CH(C6H5)-CH2-CO), 137.9, 128.7, 127.7, 127.5 (aromatic), 64.9 (CH2-CO-O-
CH2),  47.3 (O-CO-CH(C6H5)-CH2-CO-O), 37.7 (O-CO-CH(C6H5)-CH2-CO-O), 29.4 (CO-O-
CH2-CH2), 29.2 (CO-CH2-CH2-CO), 29.2 (CO-O-CH2CH2-CH2), 28.6 (CO-O-CH2CH2CH2-CH2), 
25.8 (CO-O-CH2CH2CH2CH2-CH2). 
FTIR wavenumber (cm-1): 3447 (O-H, stretching), 2925 (C-H, asymmetric stretching), 2854 (C-
H, symmetric stretching), 1731 (C=O, stretching), 1608 (aromatic C=C stretching), 1428 (C-H, 
bending), 1159 (C-O, stretching). 
2.3.2. Empty and Dye-loaded NPs formulation 
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NPs of synthesized polymers were prepared by a standard precipitation method with some 
modification [38]. Briefly, polymer (20 mg) was dissolved in 5 mL of organic solvent (acetone) to 
make a homogeneous organic phase. The organic phase was added drop-wise into 10 mL of HPLC 
grade water under stirring (1000 rpm) and stirred for 4 h at room temperature. A syringe pump 
was used to control the dropping rate (0.5 mL min-1). The formulation was then left overnight 
(open vial) to ensure the complete removal of organic solvent. The NPs suspension was then passed 
through a membrane syringe filter (pore size: 220 nm) (Millex-LG, Millipore Co., USA) to obtain 
a clear formulation. The sizes and zeta potentials of the NPs formulations were measured in HPLC 
grade water and in 10 mM HEPES buffer (pH 7.4), respectively after appropriate dilutions (100 
μg mL-1). Nanoparticle formulations were stored in a refrigerator and sizes measured after 1 month 
using the same dilution (100 μg mL-1) to determine the stability against aggregation of the particles 
upon storage. 
Coumarin-6 dye loaded NPs were prepared by a similar method as with blank nanoparticles by 
adding dye in the organic phase along with polymer. Briefly, coumarin-6 (1 mg) was dissolved 
along with the polymer (20 mg) in acetone (5 mL) and added at a fixed rate (0.5 mL min-1) to the 
HPLC grade water (10 mL). After 4 h of stirring, the formulations were stored overnight (open 
vials) to allow acetone to evaporate. The process was performed in the dark to prevent the 
degradation of light sensitive coumarin-6 dye. The precipitated polymer and dye was removed by 
filtration through a membrane filter (pore size: 220 nm). Coumarin-6 loaded NPs were passed 
through PD10 Desalting Column (Sephadex G-25 Medium, GE Healthcare Life Sciences) to 
separate the unencapsulated dye from the formulations. The purified NPs solution was used for 
further characterization. The Pluronic F-68 coating was achieved by the same method, i.e. where 
Pluronic F-68 was dissolved in an aqueous medium (0.2% w/v) to make dye loaded and empty 
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nanoparticles. The dye content was determined in freeze dried formulation. The freeze dried 
micelle was dissolved in methanol. 
The drug content was determined by freeze drying an aliquot of NP suspensions, followed by 
dissolution in methanol and quantification by UV-visible spectrophotometry at λmax = 460 nm 
(Beckman Coulter DU 800 UV spectrophotometer). 
2.3.3. Degradation study of P02 NPs formulation 
The degradation profile was assessed for the empty P02 NPs formulation in HPLC water (pH 7.4) 
and NPs formulation (in HPLC water) with Pseudomonas cepacia lipase (0.2 mg mL-1). The NP 
formulations were incubated at 37 °C. One vial from each set was collected at a predetermined 
time (30 days) and freeze-dried. The freeze-dried samples were then dissolved in chloroform, 
filtered, and analyzed by GPC to determine the change in molecular weight. 
2.3.4. C3A Cell culture 
C3A human hepatocellular carcinoma cells were cultured in MEM medium supplemented with 
10% heat-inactivated foetal calf serum (FCS), 2 mM L-glutamine, 100 U/mL 
penicillin/streptomycin, 1 mM sodium pyruvate  and 1% non-essential amino acids (termed MEM 
complete medium) and incubated at 37 °C and 5% CO2. 
2.3.5. Cell Viability assessment 
The cytotoxicity of the coumarin-6 labelled uncoated and Pluronic F68 coated P02 nanoparticles 
was determined by a fluorescence-based 3 in 1 assay [39]. This approach allows the simultaneous 
assessment of cell viability using the Alamar Blue (for metabolic activity), CFDA-AM (for cell 
membrane integrity) and Neutral Red (for lysosomal function) assays. C3A cells were seeded at a 
concentration of 1.56 x105 cells/cm2 into a 96 well plate and incubated at 37 °C and 5% CO2 for 
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24 h. Cells were then exposed to MEM complete medium (control), 1% triton X100 (positive 
control) or nanoparticles at concentrations of 4.68, 9.37, 18.75, 37.50, 75, 150 and 300 μg mL-1 
(100 L/well) and incubated at 37 °C and 5% CO2 for 24 h. Nanoparticles were prepared via 
dilution in complete MEM medium and briefly, gently vortexed prior to cell exposure 
(nanoparticles were confirmed as intact by DLS). After 24 h the supernatants were removed (and 
stored at -80 oC) and the cells were washed twice with phosphate buffered saline (PBS). A solution 
of both 1.25% v/v Alamar Blue (TREK Lab Services) and 4 µM CFDA-AM was prepared in 
phenol red free MEM medium and added to cells (100 μL) before incubating the cells in the dark 
at 37 °C and 5% CO2 for 1 h. Fluorescence was measured on a SpectraMax M5 Microplate Reader 
(Molecular Devices) at an excitation/emission of 532/590 nm for Alamar Blue and an 
excitation/emission of 485/535 nm for CFDA-AM. Next, for the Neutral Red uptake assay, cells 
were washed twice using PBS, and Neutral Red (33 µg mL-1) prepared in phenol red free MEM 
medium was added (100 µL) to cells, which were then incubated in the dark at 37 °C and 5 % CO2 
for 1 h. Following incubation, cells were washed 3 times with PBS and then acidified (1% acetic 
acid) 50% EtOH (in water) (100 µL). Cells were then incubated in the dark at room temperature 
for 20 minutes (with shaking). Fluorescence was measured in a SpectraMax M5 Microplate Reader 
at an excitation/emission of 532/645 nm. All experiments were repeated on different days, on at 
least 3 separate occasions and data reported as mean % viability (compared to the control) +/- 
standard error of the mean (SEM). GraphPad Prism 6 was used to analyze the statistical 
significance of the data. 
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2.3.6. Cell uptake studies 
2.3.6.1. Confocal microscopy 
 C3A cells were seeded (6.58 x104 cells/cm2) on 12 mm glass cover slips at 37 °C and 5% CO2 in 
24 well plates (Falcon) for 24 h. Cells were then exposed to Pluronic F68 coated and uncoated 
P02 nanoparticles at a sub lethal concentration (100 µg/mL) or MEM complete medium (control) 
for 10, 60, 240 and 1440 minutes at 37 °C and 5% CO2. Following exposure, cells were washed 
twice with PBS and fixed in 3% formaldehyde (in PBS, 250 µL) for 30 minutes in the dark at room 
temperature. Subsequently, the plates were washed twice with PBS and incubated with 50 mM 
ammonium chloride (250 µL) for 10 minutes in the dark, at room temperature. Cells were then 
washed twice with PBS before permeabilizing with 0.1% Triton-X100 (250 µL) for 20 minutes at 
room temperature. The cells were washed twice with PBS and then exposed to primary antibody 
monoclonal anti α tubulin mouse ascites fluid clone DM1A (1:200 in PBS, Molecular Probes, 250 
µL) for 1 h at room temperature. Cells were then washed twice with PBS and incubated with 
secondary antibody Rhodamine Red goat anti mouse IgG (1:100 in PBS, Molecular Probes, 250 
µL) for 1 h at room temperature. The cells were then washed twice with PBS and incubated for 5 
minutes in the dark with 1 µg mL-1 DAPI (250 µL) at room temperature to stain the nuclei. Finally, 
cells were washed twice with PBS and coverslips were mounted onto glass slides with Vector 
shield (Vector –H1000) and edges sealed with varnish. Cells were imaged using a Zeiss LSM880 
confocal microscope using the Zen program for data analyses.  
2.3.6.2. Quantification of cell uptake study 
C3A cells were seeded into 96 well plates at a concentration of 1.56 x105 cells/cm2 and incubated 
for 24 h. Cells were exposed to uncoated and coated P02 nanoparticles (4.68-300 µg mL-1) or 
MEM complete medium (control)  in duplicate for 10, 60, 240 and 1440 minutes at 37 °C and 5% 
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CO2. Following treatment cell supernatants were removed and cells were washed twice using PBS 
and 0.4% v/v Trypan Blue (50 µL) was added for 10 minutes at room temperature. Cells were 
washed twice using PBS and then lysed with 0.2% Triton X100 in the dark at room temperature 
for 20 minutes. Fluorescence was measured using a SpectraMax M5 Microplate Reader at an 
excitation/emission of 488/550 nm. All experiments were repeated on at least 3 separate occasions. 
A standard curve of fluorescence for each NP (4.68-300 µg mL-1) was generated to enable uptake 
to be quantified which was expressed as the percentage (%) of applied dose. 
2.3.7. Cytokine Production: measurement of IL-8 
Supernatants collected during the cytotoxicity testing were used for cytokine analysis. The level 
of IL-8 was quantified for selected NP concentrations (75 and 150 µg mL-1) 24 h post exposure 
using an ELISA kit, carried out following the manufacturer’s instructions (R & D systems). 
2.3.8. Genotoxicity: Comet Assay 
Oxidative DNA damage and DNA strand breaks were investigated using the 
formamidopyrimidine-DNA glycosylase (FPG) modified Comet assay.  C3A cells were seeded at 
a concentration of 1.66x105 cells/cm2 into a six well plate and incubated at 37 °C for 24 h. Cells 
were then washed with HBSS and exposed to HBSS (control), 60 μM hydrogen peroxide (H2O2, 
positive control) or the NPs (dispersed in HBBS) at a concentration of 75 and 150 µg mL-1. Cells 
were incubated at 37°C for 4 h and then washed with HBSS. Trypsin (0.25%, 1 mL) was used to 
detach the cells and complete MEM medium (3 mL) was then added to each well. The cell 
suspension was centrifuged at 850 g for 2 minutes and the cells then re-suspended in HBSS (1 
mL). The cell suspension (20 µL) was added to low melting point agarose (240 µL). The cells (125 
µL) were then pipetted onto microscope slides pre-coated with agarose. After a 10 minute period 
of solidification on ice, slides were placed in Coplin jars containing lysis buffer (66.75 mL lysis 
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buffer base (Sigma), 7.5 mL dimethyl sulfoxide, 750 μL Triton-X100) for 24 h at 4 °C. Slides were 
then washed in FPG buffer (400 mM HEPES, 1 M potassium chloride, 5 mM 
ethylenediaminetetraacetic acid [EDTA], 2 mg mL-1 Bovine Serum Albumin, pH 8 ) for 15 
minutes. The assay was conducted in the presence and absence of the enzyme FPG. FPG buffer or 
FPG enzyme in buffer (100 μL) was added to slides, covered with a cover slip and incubated at 37 
°C for 30 minutes. Slides were then transferred to a darkened electrophoresis tank cooled to 4 °C 
and covered with electrophoresis buffer (300 mM sodium hydroxide, 200 mM EDTA, 2 litres 
distilled water, pH 13). After a 20 minute period to allow for alkaline unwinding, electrophoresis 
was carried out for 20 minutes at 24 V and 270 mA. Slides were then removed from the tank and 
placed in neutralisation buffer (48.5 g Tris base, 900 mL distilled water pH 7.5) for 15 minutes at 
4 °C. Slides were then dried for 15 minutes before being dipped in 100% ethanol and stained with 
GelRed. The tail moment (tail length x total tail intensity) was assessed using a fluorescence 
microscope (Zeiss AX10 with Allied Vision Technologies Stingray camera) connected to image 
analyzing software (Comet Assay IV: Perceptive Instruments, UK). Fifty cell measurements were 
recorded for each slide per experiment. 
Data in Figures are means ± standard error of the mean (SEM). Data for the two particle types 
were compared to the control values and each other using an ANOVA with Tukey’s multiple 
comparison for the tail moment. All statistical tests were performed using Minitab 15. A p value 
<0.05 was considered a significant value. For the two particle types the experiment was repeated 
a minimum of three times. 
  
3. Results 
3.1. Synthesis and characterization of the polymers 
The synthesis and structures of the polymers are shown in Scheme 1. 
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Scheme 1: Synthesis of polymers P01-P05 using polycondensation reactions. 
Polyesters P01-P05 were produced from the corresponding diol and diacid monomers by 
solvent-free polycondensation using 0.05 % Sc(OTf)3 as the catalyst. The physical state of 
the purified final materials varied from solid to viscous liquid, depending on their co-
monomer composition. The poly(decamethylene succinate) ester (P01) was a colourless 
solid whereas the polymers prepared with phenylsuccinic acid and decanediol were viscous 
light brown oils. The polymers containing both of the acid components ranged from solids 
to viscous oils according to phenyl content. The isolated yields of the polymers were 
typically 90-95%. The characterization data of the synthesis and the polymers are given in 
Table 2. 
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Table 2. Polymers (P01-P05): synthesis, composition (mol % of diacid) and molecular weight (g 
mol-1)  
Polymer 
Code 
Feed 
Ratio (mol%) 
Product 
Ratio (mol %)* 
Molecular Weight 
(g mol-1)$ Yield 
(%) 
SA PSA SA PSA Mn Mw 
PDI 
(Mw/Mn) 
P01 100 0 100 0 11500 42200 3.66 94 
P02 70 30 70 30 11500 37600 2.87 93 
P03 50 50 50 50 10100 34200 3.39 92 
P04 30 70 30 70 11000 34400 3.13 91 
P05 0 100 0 100 11600 37600 3.24 90 
* Determined by 1H NMR spectroscopy; $ Determined by gel permeation chromatography (GPC) 
using CHCl3 as the mobile phase.  SA: Succinic acid, PSA: Phenylsuccinic acid, Mn: Number 
average molecular weight, Mw: Weight average molecular weight, PDI: Polydispersity Index. 
 
The polymers showed number average molecular weights (Mn) ranging from 10,100-11,600 g mol
-
1 as determined by gel permeation chromatography (GPC). The polydispersity indices were similar 
for all the polymers and hence the materials were considered suitable for comparative studies. The 
monomer composition of polyesters P01-P05 was determined by 1H NMR spectroscopy (Figure 
S1, S3, S5, S7 and S9). The peak assignment was further confirmed by 2D COSY NMR (Figure 
S2, S4, S6, S8 and S10) and 13C NMR spectrum (Figure S 11).   
The differential scanning calorimetry (DSC) data showed a pattern for the thermal properties of 
the polymers (Table 3). The melting temperature (Tm), crystallization temperature (Tc) and melting 
enthalpy (∆H) were found to decrease with increasing phenyl content (Figure S12, Table 3). For 
P04 and P05 no Tm were detectable and only glass transition temperatures (Tg) were observed. The 
glass transition temperatures for all the polymers were in the -40 to -30 °C range. The P01 polymer 
with no phenyl side chains showed a sharp melting temperature, but no glass transition temperature 
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was detected. Figure S12 shows the trend in the melting temperatures (Tm), glass transitions 
temperatures (Tg) and crystallization temperature (Tc) of the synthesized polyesters P01-P05.  
Table 3. Thermal properties and physical properties of the synthesized polyesters with different 
phenyl side-chain content. 
Polymer 
Code 
Product 
Ratio (mol%) 
Thermal Property 
Physical  
property 
SA PSA 
Tg 
(oC) 
Tm
 
(oC) 
Melting 
Enthalpy 
(∆H) J/g 
Tc 
 (oC) 
P01 100 0 ND 71 124 49 Crystalline 
P02 70 30 -39 45 44 19 Semicrystalline 
P03 50 50 -38 35 32 4 Semicrystalline 
P04 30 70 -40 ND ND ND Amorphous 
P05 0 100 -34 ND ND ND Amorphous 
ND:Not detected; SA:Succinic acid; PSA:Phenylsuccinic acid. Tg: Glass transition 
temperature,  (Tg) (B) Tm: melting temperature; Tc: crystallization temperature
 
3.2. Preparation and characterization of nanoparticles 
Polymers of similar molar mass but with differences in their phenyl content were investigated to 
determine if side-chain content and Tg/Tm variation had any effect on their ability to encapsulate 
model drugs. The polymers were mixed with a fluorescent dye, coumarin-6 (C log P ~ 6, as a 
model for highly lipophilic drugs) prior to nanoprecipitation from a common solvent (acetone) to 
a non-solvent (water). The characteristics of the polymers following nanoprecipitation and dye 
loading are given in Table 4. 
Table 4 Characteristics of empty and dye loaded NPs of various polymers. 
Polymer 
Empty 
Nanoparticles£ 
Dye Loaded 
Nanoparticles£ 
Zeta 
potential 
(mV) 
(±SD) 
 
Drug Content 
(%) ± SD 
 
Average 
Size (nm) 
PDI 
Average 
Size (nm) 
PDI 
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P01 144 ± 6 0.09 ± 0.02 146 ± 9 0.10 ± 0.02 -39 ± 9 ND 
P02 160 ± 7 0.03 ± 0.01 168 ± 7 0.05 ± 0.01 -40 ± 7 0.28 ± 0.01 
P03 163 ± 8 0.06 ± 0.02 166 ± 5 0.07 ± 0.02 -38 ± 5 0.23 ± 0.02 
P04 165 ± 6 0.10 ± 0.03 172 ± 6 0.09 ± 0.02 -39 ± 6 0.12 ± 0.01 
P05 164 ± 4 0.09 ± 0.02 167 ± 7 0.08 ± 0.02 -41 ± 6 0.05 ± 0.01 
P02* 185 ± 5¥ 0.07 ± 0.02 206 ± 6 0.08 ± 0.02 -21 ± 6$ 0.23 ± 0.02 
*Pluronic F68-coated P02 NPs. £Determined in HPLC water using Dynamic Light Scattering 
(DLS) Technique. ¥Significant difference in size from dye loaded P02* NPs (p < 0.05, unpaired 
student’s t test).  $Significant difference in zeta potential from P02 NPs (p < 0.05, unpaired 
student’s t test). 
 
At ambient temperature P01 polymer was found to be poorly soluble in the organic phase (acetone) 
compared to the other polymers, and needed to be dissolved at ~ 40 °C prior to nanoprecipitation. 
The method of nanoprecipitation was optimized for solvent to non-solvent and polymer to 
coumarin-6 dye ratios. A difference in the color intensity (yellow) was observed when the 
nanosuspensions were passed through a 0.22 µm filter to remove large aggregates. No significant 
change in dye loading was observed when the formulation was dialyzed for 9 h using 12 kDa 
membranes, indicating that the dye was loaded only in the nanoparticles and was not loosely 
associated with the nanoparticle surfaces. In general, the entrapped dye content was decreased as 
the content in phenyl side-chains in the polymer increased. No dye was detected in the NPs made 
from P01 polymer. The dye loading was found to be highest with PDeMS-co-PS (P02) polymer, 
with 30% phenylsuccinic acid in its diacid repeating units, compared to other synthesized 
polymers, although the overall amounts of incorporated dye were still low. The amount of 
incorporated coumarin-6 dye decreased as the proportion of phenyl side chains increased from 30 
to 100% of total diacid content (Figure 1). Nanoparticles made from P02 polymer were also 
formulated for enhanced suspension stability by the adsorption of Pluronic F68, which 
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significantly changed the zeta potential from -40 mV to -21 mV in dilute HEPES buffer. The 
particle sizes of the NPs following storage for one month were statistically insignificantly different 
compared to those of NPs before storage (p > 0.05, unpaired Student’s t test) indicating good 
colloidal stability of the formulated NPs. The dye loading was significantly decreased (P < 0.05, 
unpaired student’s t test) when uncoated P02 NPs formulations were compared against the Pluronic 
F68 coated P02 NPs formulation, although again the overall loading was low (Figure 1). 
 
 
Figure 1: Coumarin 6 loading (wt% to polymer) in copolymers P01-P05. Each point represents 
mean dye content (wt% to polymer) ± SD (n=3). ND: Not detected. P02*: Pluronic F68-coated 
P02 NPs. A significant difference in dye incorporation (p < 0.05, unpaired Student’s t test) was 
observed between P02 and P02* NPs. 
There was no significant difference in the sizes observed between empty and dye loaded P02 NPs. 
The Pluronic F68 coating significantly increased the size of the P02 NPs compared to uncoated 
P02 NPs and the dye loaded P02 NPs coated with Pluronic were also of significantly higher size 
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compared to empty Pluronic coated P02 NPs (Table 4). As expected, the Pluronic coating 
stabilized the P02 NPs compared to uncoated P02 NPs when diluted in PBS. Dynamic light 
scattering of P02 NPs in HPLC water showed essentially one population group of particles whereas 
two distinct populations were observed when the same uncoated P02 NPs were diluted in PBS. In 
contrast, Pluronic F68 coated P02 NPs retained a unimodal population distribution after dilution 
in both of the media (HPLC water and PBS). Additionally there was a significant difference 
between the zeta potential of coated (-40 ± 7) and uncoated (-21 ± 6) P02 NPs when dispersed in 
HEPES 10 mM buffer (pH-7.4). The TEM images of uncoated and Pluronic coated P02 NPs 
showed a uniform distribution of spherical nanoparticles (Figure 2).  
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Figure 2: Size distribution of NPs as determined using DLS of suspensions (100 μg mL-1) in 
HPLC water and PBS. (A) Uncoated P02 nanoparticles in HPLC water, (B) Uncoated P02 NPs 
in PBS, (C) Pluronic coated P02 NPs in HPLC water, (D) Pluronic coated P02 NPs in PBS, (E) 
TEM of uncoated P02 NPs, and (F) TEM of Pluronic coated P02 NPs. 
 
As previously noted, uncoated (P02) NPs were significantly smaller (140 ± 1 nm) than coated 
(P02*) NPs (146 ± 1 nm) when dispersed in MEM complete medium (Table 5). The zeta potentials 
of P02 (-12.67 ± 0.37mV) and P02* (-10.68 ± 0.75 mV) NPs (in MEM complete medium) were 
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negative. The size variations for both NPs when dispersed in complete MEM medium were low, 
ranging from polydispersity indices of 0.13 ± 0.01 for uncoated P02 NPs to 0.22 ± 0.01 for coated 
P02* NPs, therefore indicating that the NPs were stable in media as well as in HPLC water.   
Table 5: Characteristics of nanoparticles in MEM complete medium.  
NP  
Hydrodynamic  
Diameter (nm)# 
Zeta Potential 
(mV)# 
Polydispersity Index 
(PDI)# 
P02 140 ± 1 -12.7 ± 0.4 0.13 ± 0.01 
P02* 146 ± 1$ -10.7 ± 0.8 0.22 ± 0.01$ 
# P02 and P02* NPs were dispersed in complete MEM medium (125µg/ml) prior to dynamic light 
scattering measurements.*Pluronic F68 adsorbed onto the surface of the P02 nanoparticles. $ 
Significant difference (p<0.05) from uncoated P02 nanoparticles, Data are expressed as average ± 
SEM (n = 3). 
 
3.3. Degradation of P02 nanoparticle formulations 
Polymer degradation profiles are important in polyesters designed for sustained release, as these 
data provide valuable information related to in vivo fate and long term formulation storage. 
Degradation of the selected P02 formulation was monitored at specific time intervals (30 days) in 
the presence and absence of a model hydrolytic enzyme, Pseudomonas cepacia lipase (0.2 mg mL-
1). The presence of the lipase resulted in a reduction in the polymer Mn to 53% of its original value 
after 3 months. Conversely, a drop of only 12% in Mn was observed in the absence of enzyme 
(Figure 3).  
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Figure 3: Loss in molar mass (Mn) of P02 NPs with time in the presence and absence of 
Pseudomonas lipase (0.2 mg mL-1) at 37 oC. 
3.4. Impact of NPs on C3A cell viability  
The effects following exposure of C3A hepatocytes to P02 NPs (in the presence and absence of a 
Pluronic F68 coating) were assessed using the Alamar Blue (AB), 5-carboxyfluorescein diacetate, 
acetoxymethyl ester, (CFDA-AM), and Neutral Red (NR) assays. For all assays, cell viability (as 
a proxy for a specific activity) was more than 80% for both coated and uncoated P02 nanoparticles 
24 h post exposure, at a concentration range (4.6 to 300 μg mL-1) relevant to polymeric 
nanomedicines administered in vivo (see Supplementary Information for calculations).. Although 
dosing at 150 and 300 µg ml-1 for coated P02 (Figure 4) using the NR assay indicated a statistically 
significant decrease in cell viability, this was not considered to be biologically relevant as these 
were concentrations well above those likely to be used in a clinical setting and even at these 
concentrations, the overall viability decrease was no more than 20 %. Nevertheless, this decrease 
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might be an indicator of effects on the lysosomal function of C3A cells which could occur after 
accumulation of these polyester NPs.  
 
Figure 4: Viability of C3A hepatocytes following exposure to Pluronic F68 coated (red) and 
uncoated (black) P02 NPs. Cells were exposed to for 24 h with cell viability assessed via Alamar 
Blue (A), CFDA (B) and Neutral Red (C) assays. Data are expressed as the average percentage 
of cell viability (% of the control (MEM complete medium exposed cells) ± SEM (n = 3 
minimum). 
3.5. Cellular uptake of NPs by C3A cells 
Imaging of the uptake of coated and uncoated P02 nanoparticles by C3A cells suggested that both 
types of the nanoparticles were readily taken up by cells within 10 min of exposure. The NPs were 
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present both on the surface of the cells and were internalized into the cell interior (confirmed via 
z stack images). The internalization of both types of P02 nanoparticles increased progressively 
over time from 10-1440 minutes, and in all cases NPs were predominately located within the 
cytoplasm of cells. 
Initially (10 minutes post exposure) both types of NPs were observed to be compartmentalized 
inside and between the cells, although a more diffuse pattern of uptake was observed at 1440 mins 
(Figures 5 and 6), particularly in relation to the coated P02* NPs.  In addition, some fluorescence 
was detected from within the nucleus after 1440 minutes but due to the resolution (approximately 
200 nm) of the microscope it was not possible to distinguish individual nanoparticles. For uncoated 
NPs, vacuoles containing fluorescence adjacent to the nucleus could be seen from 10 min. 
Internalization of NPs into the cell interior were confirmed via z stacks (Figure 7).  
Quantification of coated and uncoated P02 nanoparticle uptake confirmed the findings obtained 
from confocal microscopy. The extent of NP uptake by cells was concentration and time dependent 
(Figure 8).  For both NP types the greatest level of uptake was observed at 1440 min. The uncoated 
P02 NPs showed the highest level of uptake at 3.8% of the applied dose internalized at 150 µg mL-
1 after 1440 min treatment. The greatest level of uptake for Pluronic F68 coated P02 NPs was 
observed at 1440 min, with 2.7% of the applied dose internalized at a concentration of 300 µg mL-
1. 
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Figure 5: The time dependent uptake of coumarin-6 labelled uncoated P02 nanoparticles by 
C3A cells. Cells were treated with MEM complete medium (A) or NPs (100 µg mL-1) for 10 
(B), 60 (C), 240 or (D) 1440 minutes (E). Following exposure cells were fixed and stained for 
the tubulin cytoskeleton (red) and nucleus (blue). The green color represents coumarin-6 loaded 
NPs. Any yellow color observed indicates co-localization of tubulin and NPs. The scale bars 
represent 5 µm. 
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Figure 6: The time dependent uptake of coumarin-6 labelled Pluronic F68 coated P02 
nanoparticles by C3A cells. Cells were treated with MEM complete medium (A) or NPs (100 
µg mL-1) for 10 (B), 60 (C), 240 or (D) 1440 minutes (E).Following exposure cells were fixed 
and stained for the tubulin cytoskeleton (red) and nucleus (blue). The green color represents 
coumarin-6 loaded NPs. Any yellow color observed indicates co-localization of tubulin and NPs. 
The scale bars represent 5 µm. 
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Figure 7: Internalization of uncoated P02 and Pluronic F68-coated P02 (P02*) fluorescent NPs 
over time by C3A cells. Images represent Z-stacks from which xy and yz micrographs were 
generated to confirm internalization of NPs. Cells were treated with 100 µg mL-1 NPs for 10 
min (A), 60 min (B), 240 min (C) and 1440 min (D) and then fixed. Tubulin cytoskeleton is 
represented by red, the nucleus by blue and the NPs by green. Co-localization of NPs and tubulin 
is represented by yellow. 
P02 NPs (Uncoated)
A B C D
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Figure 8: Quantification of the uptake of coated and uncoated P02 NPs in C3A cells over time 
at a range of concentrations (4.6-300 µg mL-1). Cells were treated for 10 min, 60 min, 240 min 
and 1440 min with uncoated P02 NPs (A) or coated P02* NPs (B). The Percent (%) applied 
dose was calculated from the relevant standard curves. 
 
3.6. Cytokine Production  
No change in cytokine production (IL-8) by C3A cells was detected at the NP concentrations tested 
24 h post exposure, compared to the control (data not shown). 
3.7. Genotoxicity  
The results in Figure 9 show that at 4 h post exposure, the Pluronic F68 coated P02* NPs induced 
DNA damage in C3A cells at both (sub-lethal) concentrations, when tail moment was used as a 
measure of genotoxicity. In the absence of FPG, Pluronic coated NPs, at a concentration of 75 µg 
mL-1, induced a significant (p < 0.01) 3 fold increase in DNA damage in C3A cells, when compared 
to the control. At a concentration of 150 μg mL-1, coated NPs induced a significant (p < 0.05) 1.6 
fold increase in DNA damage, compared to the control. In the presence of FPG, coated NPs, at a 
concentration of 150 µg mL-1, induced a significant (p <  0.001) 4 fold increase in DNA damage, 
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compared to the control treatment (in the presence of FPG). Uncoated NPs did not induce DNA 
damage at the concentrations tested, in the presence or absence of FPG. The positive control H2O2, 
at a concentration 60 μM, induced significant (p < 0.001) DNA damage both in the presence and 
absence of FPG, with enhanced DNA damage observed in the presence of FPG. Pluronic F68 
(alone) did not induce DNA damage (data not shown). 
 
Figure 9: Genotoxicity. C3A cells were exposed to HBSS (control), 60 µM H2O2, P02 (uncoated) 
and P02* (coated) NPs (at concentrations of 75 µg mL-1 and 150 µg mL-1) for 4 h.  DNA damage 
was assessed using the Comet assay in the presence and absence of FPG. Data are expressed as 
average tail moment ± SEM (n=3). Significance is indicated by *** = p<0.001, ** = p < 0.01 and 
* = p < 0.05 when compared with HBSS control. $$$ = p < 0.001 and $$ = p < 0.01 when compared 
to P02 (uncoated) NPs at the same concentration in the presence and absence of FPG. 
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This study generated polyesters with varying degrees of phenyl groups in their side chains which 
in turn varied with respect to their crystallinity and ability to load a model drug compound. The 
use of scandium (III) triflate enabled the reactions to be free of organic solvent and to generate 
polyesters of similar molar masses repeatable over several batches of synthesis. Differences in Tg 
and Tm in the polymers indicated differences in chain packing of the materials: polymers with high 
phenyl content (P04-P05) showed only a Tg while the absence of Tm and Tc indicated that these 
polymers were amorphous. Since it is known that aromaticity, glassiness, and crystallinity in 
polymers can affect other properties such as drug loading, release and biodegradability, NPs of the 
polymers varying in their physical properties were prepared in the presence of a dye molecule 
(coumarin-6). The highest loading of coumarin-6 was observed for the P02 polymeric NPs. This 
was not expected from first principles as the ring systems of the dye were expected to interact more 
favorably with polymers containing high phenyl content through mutual  interactions. In 
addition, the polymers with higher phenyl content were amorphous hence were expected to 
encapsulate more dye due to the higher free volumes in the amorphous core regions. These initially 
contradictory results can be explained by considering three factors important during 
nanoprecipitation; (1) polymer-polymer interaction (2) dye-dye interaction (3) dye-polymer 
interaction. For a higher loading, a favorable dye-polymer interaction is important to maintain a 
close proximity of dye and polymer during the late stages of nanoprecipitation. However, a higher 
polymer-polymer interaction and dye-dye interaction can cause a reduction in the dye loading 
during nanoprecipitation. For the P01 polymer, which contained no phenyl succinate residues, it 
is likely that a high polymer-polymer and dye-dye interaction caused the molecules to precipitate 
resulting in a low yield of well-defined NPs and with no detectable dye content. As the phenyl 
content was increased for the P02 polymer, a more favorable interaction between dye and polymer 
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may have resulted hence the higher dye loading. However, upon further increase of phenyl content 
in the polymer (P03, P04 and P05), the higher  interactions between polymer molecules, rather 
than dye-polymer molecules resulted in lower loading capabilities. Since the P02 polymer (70:30 
succinic acid and phenyl succinic acid) exhibited the highest dye loading capability when 
formulated into NPs, subsequent assessment of the degradability of the polymers and its effects on 
hepatic cells were prioritised. Molar mass profiles over time revealed that P02 polymer NPs were 
degradable, although the low degradation rate of the polymer at pH 7.4 indicated that the polymer 
was quite resistant to primary hydrolytic cleavage. The presence of esterolytic enzymes increased 
the degradation rate suggesting that the polymer should be degraded in the body more rapidly if in 
contact with endogenous esterases.  
Prior to cytocompatibility experiments, potential factors affecting cell association uptake and 
uptake of the polymeric nanoparticles were evaluated. The hydrodynamic diameters of P02 
(uncoated) NPs were less than those of P02* (coated) NPs, as expected due to the absorbed 
Pluronic coating on P02* NPs but the differences were less than 10% so were unlikely to impact 
on endocytic uptake mechanisms.[40] There is evidence that particle charge influences particle-
cell interactions and uptake, and the charge of NPs can also reflect dispersion stability and the 
potential for agglomeration. As a consequence zeta potential is often used as an indicator of charge 
when characterizing NP properties.[41] The zeta potentials of both P02 and P02* NPs were 
negative, ranging from -10.7 to -12.7 mV, and in biologically relevant media the differences in 
zeta potential between the coated and uncoated NPs were not statistically significant, suggesting 
that NP charge alone was unlikely to influence particle-cell interactions.   
A 3 in 1 assay (Alamar Blue, CFDA-AM and Neutral Red) was used to assess viability of cells 
exposed to the polymer NPs. Furthermore, using 3 different assays which assess different cell 
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responses as indicators of cytotoxicity can provide information on the mechanism of NP toxicity. 
All three assays indicated that the coated and uncoated P02 NPs exhibited low acute toxicity in the 
experimental conditions tested. A greater sensitivity was observed with the Neutral Red assay 
showing statistically significant effects on normal lysosome function at high concentrations of 
Pluronic F68 coated P02 NPs, although the small changes in cell viability observed were not 
considered to be of potential biological significance. 
Assessment of cytotoxicity at 24 h allows for comparison of results obtained in this study to those 
obtained in prior literature as the majority of nanotoxicology studies evaluate cytotoxicity 24 h 
post exposure using the C3A cell line and other cell types (e.g. immune cells, epithelial cells).[42, 
43] A limitation of in vitro studies is that it is more challenging to assess chronic toxicity. In future 
studies the development of in vitro assays which enable toxicity to be assessed after repeated 
exposures or longer exposure periods would allow for the assessment of recovery or increased 
cytotoxicity over time. 
In order to evaluate the toxic potency of NPs, the lethal concentration (LC50) can be calculated, 
which identifies the concentration of NPs required to kill 50% of cells. No LC50 values could be 
calculated for the NPs tested in this study, despite concentrations up to 300 µg mL-1 being tested. 
Previous studies which have investigated the response of C3A cells to engineered NPs (e.g. silver, 
zinc oxide) at a similar concentration range tested in this study, have calculated LC50 values of 
approx. 2 µg mL-1 [44], demonstrating the relatively low toxicity of the polymeric NPs tested in 
this study. 
Toxicity testing is performed in different phases. By screening the toxicity of the polymeric NPs 
in vitro in the first instance, a rapid assessment of the toxicity of NPs of varied physico-chemical 
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properties is possible. Performing in vitro studies also allowed the mechanism of toxicity to be 
probed in a cost and time efficient manner, and ensured that the study was aligned with the 3Rs 
principles (reduction, refinement and replacement of animal testing). Although cell lines can lose 
functions present in primary cells and therefore have been criticized for their lack of relevancy, 
previous studies have demonstrated that the C3A cell line is able to replicate the response of human 
and rat primary cells to many different types of NPs [44]. This is particularly important as it is 
well established that cells vary widely in their sensitivity when exposed to a range of nanomaterials 
[45].  
NPs are known to elicit toxicity via mechanisms involving stimulation of inflammation and 
oxidative stress [46], which are driven by their physico-chemical characteristics (e.g. composition, 
size, charge). The stimulation of inflammatory and oxidant driven responses can induce a number 
of downstream consequences such as genotoxicity or cell death. Cytokine production was used as 
an indicator of the pro-inflammatory effects of the NPs in this study.  No IL-8 production was 
stimulated by NPs following exposure of C3A cells. NPs such as silver and zinc oxide have 
previously been observed to stimulate IL-8 production [44], oxidative stress [47]  and genotoxicity 
[47] in C3A cells. Additionally, in vivo studies in mice using cationic NPs for DNA delivery have 
shown increased levels of chemokine KC, the homolog of human IL-8.[48] Accordingly 
assessment of NP mediated IL-8 production from hepatocytes was prioritised in this study. No 
changes in IL-8 production were observed following exposure of cells to P02 and P02* NPs, and 
while we cannot rule out production of other cytokines (e.g. TNF-a, IL-6) in response to 
stimulation by NPs in these C3A cells, our primary screen based on IL-8 suggested no exceptional 
pro-inflammatory activation. It is also possible that any cytokine proteins produced by cells may 
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also have adsorbed to the NP surfaces, preventing their detection [49], although we did not 
specifically measure for adsorbed proteins. 
Pluronic F68-coated NPs were observed to stimulate DNA damage in C3A cells, whilst uncoated 
NPs did not induce a response. DNA damage induced by Pluronic coated NPs was enhanced in 
the presence of FPG which suggests that the damage is mediated by an oxidant mechanism. The 
NPs themselves may have had intrinsic oxidative activity, as well as the ability to induce 
production of intracellular reactive oxygen species (ROS) when interacting with the cells to result 
in an imbalance between oxidants and antioxidants with in the cell.[50] Data obtained suggested 
that the Pluronic F68 coating enhanced the genotoxicity of the NPs in this study. It has been 
previously shown that certain Pluronic co-polymers can elicit transcriptional activation in cell lines 
under certain conditions, and effects on complement activation have been known for these 
polymers for many years [51, 52]. However, it is unlikely that the genotoxicity observed here 
derived from the leaching of the amphiphilic co-polymer from the NP surfaces, as when Pluronic 
F68 alone was administered to cells, at a concentration equivalent to that contained in the NPs, no 
genotoxicity was observed. Nevertheless, since the properties of different Pluronics change with 
concentration and aggregation status [53] a possible effect on key cellular components of Pluronics 
associated at block co-polymer surfaces cannot be ruled out. Work by Kabanov et al demonstrated 
that Pluronic P85 co-polymers were able to cause energy-depleting effects in multi-drug resistant 
(MDR) cells, [54] where it was suggested that depletion occurred partially by membrane 
permeabilisation and possible release of reactive oxygen species (ROS). In prior studies of 
mitochondrial membrane disruption [55], Pluronic P85 was shown to be less potent than Pluronic 
F68 but more active than a higher molar mass Pluronic, L121. These previous data had indicated 
a ‘hotspot’ of membrane-disruption for the Pluronic co-polymers with central hydrophobic 
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poly(propylene oxide) block lengths of ~2000 Da, similar to that in Pluronic F68. Specific effects 
of the F68 coating may thus have accounted for the observed increase in genotoxicity, and it should 
be noted that Pluronic F68 has been shown to increase the production of interferon  in Chinese 
Hamster Ovary cells, [56] albeit at much higher concentrations than in our assays, through a 
mechanism that likely involved partial or temporary membrane modification. 
Evaluation of the uptake and intracellular fate of nanoparticles intended for medical use is 
important as carrier materials are often required to enter the cell in order to deliver a therapeutic 
or identify a disease phenotype [57]. Previous studies have indicated that uptake efficiency and 
subcellular localisation can influence material cytotoxicity [58]. Therefore, it is important to 
elucidate the uptake pattern of the polyester NPs, particularly in hepatic cell lines, as it is well 
established that the liver is a site of accumulation for many nanoparticles following exposure via 
various routes (e.g. intravenous injection, ingestion, inhalation/intratracheal instillation) [34, 35, 
37]. The uptake of coated and uncoated P02 NPs in C3A cells suggested that the NPs were taken 
up by the cells in a time and concentration dependent manner. Previous studies have indicated that 
the uptake of polymer NPs by cells increased with time in other cell lines (e.g. macrophages), 
although these studies did not look at the impact of NP concentration on uptake and assessed 
uptake over a shorter time frame [59, 60]. Different cell types vary with respect to their efficiency 
at internalising NPs. Existing studies have investigated the uptake of NPs by macrophages in vivo 
and in vitro, due to their prominent role in particle clearance from the body (e.g. lungs, liver). The 
predominant mechanism of particle uptake by hepatocytes and thus the most likely route of uptake 
in this study is endocytosis, which has a lower efficiency than phagocytosis. Interestingly, similar 
overall levels of uptake compared to those of P02 and P02* in C3A cells have been noted for 
carboxymethyl chitosan NPs in the L02 hepatocyte cell line.[61] In this study the polyester NPs 
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were primarily compartmentalized within and between C3A cells as early as 10 minutes post 
exposure. At the later time point of 1440 minutes the polyester NPs were observed throughout the 
cytoplasm of the C3A cells. The subcellular fate of internalized NPs was not investigated in this 
study, however the pattern of uptake observed suggests that these particular NPs were initially 
located within the cell organelles such as endosomes or lysosomes. P02 NPs were observed to 
accumulate in lysosomes of the J774 macrophage cell line 1 h post exposure (data not shown) and 
polystyrene NPs and quantum dots have also been observed to accumulate in lysosomes and 
mitochondria of macrophages in vitro [62]. Current studies are investigating the subcellular 
localization to better understand the fate of internalized polyesters from these formulations.  
NPs were also seen to accumulate between cells, which may be representative of accumulation in 
bile canaliculi. These structures are responsible for the formation and secretion of bile by 
hepatocytes and could be indicative of NP removal from the cells. Interestingly, the elimination of 
polystyrene NPs (20 nm) in bile has been observed previously in vitro and in vivo [60].   
The co-localization of NPs with tubulin was also observed in this study, particularly within the 
perinuclear region of the cell. Research has shown that tubulin may be involved with the directional 
transport of NPs within the cell and this transport can be targeted towards the nucleus [63]. NPs in 
vacuoles in close proximity to the nucleus could also suggest targeted delivery to the nucleus, 
although the size of these particular NPs would likely prohibit them crossing an undamaged 
nuclear membrane. At 24 h post exposure, coated NPs appeared to become diffuse throughout the 
cell, whilst the majority of uncoated NPs remained compartmentalized, suggesting that the 
Pluronic coating may have had an impact on the intracellular fate of NPs. NPs may thus have been 
partially degraded within certain cell organelles (e.g. lysosomes) via hydrolytic enzymes known 
to degrade polyesters [64], and thus any dye associated near the NP surfaces may have been 
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released into the cytoplasm. It is also possible that the P02 NPs escaped the organelles to distribute 
throughout the cytoplasm. An increase in the number and size of vacuoles within cells treated with 
Pluronic coated (P02*) NPs was also apparent which may indicate damage to the cells had 
occurred over time. 
 
5. Conclusion 
In this study, the synthesis of a new series of polyesters by melt polycondensation under solvent-
free conditions has been described and the effects of co-monomer content on polymer properties 
(e.g. crystallinity) and nanoparticle properties (e.g. size, dye loading) relevant to controlled release 
applications have been evaluated. The study suggested that side chain phenyl content changed the 
loading capability of NPs for a model dye, but the overall level of incorporation remained very 
low. The study provided information about the stability, and degradability of a selected P02 
polymer when formulated into Pluronic coated and uncoated nanoparticles. The cellular studies 
revealed that P02 NPs displayed low cell toxicity and were effectively taken up by the cells. 
However, the Pluronic coating appeared to enhance some aspects relating to the toxicity of the 
NPs, and this information should be used to inform the design of formulated NPs in the future.  
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